Delivery Order SPE2DR25D3103-SPE2DR26F9L91
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $8,586.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a $2,981.76 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,870.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) with an ultimate completion date of October 20, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,847.30 by the Defense Logistics Agency on October 23, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). The award is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 24, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets in December 2025, valued at $8,085.56 under a firm fixed-price contract. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The product will be delivered to AmerisourceBergen's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $9,945.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $10,439.22, with an ultimate completion date of November 25, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $5,638.58 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The delivery order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,873.72 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit package) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9L91Delivery Order
The Defense Logistics Agency awarded a $49,790.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Vemlidy 25 mg tablets. This is a non-set-aside award issued on December 4, 2025, with an ultimate completion date of December 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen maintains a comprehensive portfolio of medical supply contracts with the Defense Logistics Agency supporting military and veteran healthcare programs. The company's IDC vehicle enables flexible procurement of a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains. Vemlidy is an antiviral medication used in hepatitis B treatment, reflecting the diverse pharmaceutical needs supported through the DLA's medical supply chain for defense and military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.8k | 12/3/25 |